financetom
Business
financetom
/
Business
/
Cannae Holdings Insider Sold Shares Worth $2,478,697, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Cannae Holdings Insider Sold Shares Worth $2,478,697, According to a Recent SEC Filing
Sep 3, 2025 11:26 AM

02:04 PM EDT, 09/03/2025 (MT Newswires) -- Frank R Martire, Director, on August 29, 2025, sold 133,333 shares in Cannae Holdings ( CNNE ) for $2,478,697. Following the Form 4 filing with the SEC, Martire has control over a total of 199,619 common shares of the company, with 199,619 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1704720/000112760225021115/xslF345X05/form4.xml

Price: 18.77, Change: +0.22, Percent Change: +1.19

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Maersk could offer limited Baltimore barge service
Maersk could offer limited Baltimore barge service
Apr 24, 2024
COPENHAGEN, April 24 (Reuters) - Denmark's Maersk may resume some shipping services at the U.S. Port of Baltimore when a temporary channel is opened to give access for commercially essential vessels that remain blocked by a collapsed bridge, the company said on Wednesday. This channel, with a controlling depth of 20 feet, could potentially allow Maersk and other carriers to...
Travere Therapeutics Says Berger's Disease Treatment Granted EU Conditional Marketing Authorization
Travere Therapeutics Says Berger's Disease Treatment Granted EU Conditional Marketing Authorization
Apr 24, 2024
04:27 AM EDT, 04/24/2024 (MT Newswires) -- Travere Therapeutics ( TVTX ) and CSL Vifor said Wednesday the European Commission granted conditional marketing authorization for Filspari as a treatment for adults with primary Immunoglobulin A Nephropathy, or Berger's disease. CSL Vifor expects to launch sales of the drug in Europe beginning in H2. The authorization for the treatment, also known...
FOXO Technologies Gets Non-Compliance Notice From NYSE American
FOXO Technologies Gets Non-Compliance Notice From NYSE American
Apr 24, 2024
04:01 AM EDT, 04/24/2024 (MT Newswires) -- FOXO Technologies ( FOXO ) said late Tuesday it received a notice from the NYSE American that it is not compliant with the exchange's listing rules due to its failure to timely file its 2023 annual report on Form 10-K. The delay was attributed to significant changes and restructuring activities in 2023 and...
SK Hynix to invest $3.86 billion in DRAM chip production base in South Korea
SK Hynix to invest $3.86 billion in DRAM chip production base in South Korea
Apr 24, 2024
SEOUL (Reuters) - South Korean memory chipmaker SK Hynix said on Wednesday it plans to invest 5.3 trillion won ($3.86 billion) to build a chip factory for a new dynamic random access memory (DRAM) chip production base in South Korea. The Nvidia supplier plans to start construction at the chip factory, called M15X, at the end of April with an...
Copyright 2023-2026 - www.financetom.com All Rights Reserved